Cargando…

Human Cancer and Platelet Interaction, a Potential Therapeutic Target

Cancer patients experience a four-fold increase in thrombosis risk, indicating that cancer development and progression are associated with platelet activation. Xenograft experiments and transgenic mouse models further demonstrate that platelet activation and platelet-cancer cell interaction are cruc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Shike, Li, Zhenyu, Xu, Ren
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2018
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5979598/ https://www.ncbi.nlm.nih.gov/pubmed/29677116 http://dx.doi.org/10.3390/ijms19041246

Ejemplares similares

Hsp47 promotes cancer metastasis by enhancing collagen-dependent cancer cell-platelet interaction
por: Xiong, Gaofeng, et al.
Publicado: (2020)

Emerging roles of platelets in cancer biology and their potential as therapeutic targets
por: Wang, Lei, et al.
Publicado: (2022)

Platelet–Eosinophil Interactions As a Potential Therapeutic Target in Allergic Inflammation and Asthma
por: Shah, Sajeel A., et al.
Publicado: (2017)

MicroRNA-34a: a potential therapeutic target in human cancer
por: Li, X J, et al.
Publicado: (2014)

USP10 as a Potential Therapeutic Target in Human Cancers
por: Tao, Li, et al.
Publicado: (2022)

Frizzled Receptors as Potential Therapeutic Targets in Human Cancers
por: Zeng, Chui-Mian, et al.
Publicado: (2018)

RORα, a Potential Tumor Suppressor and Therapeutic Target of Breast Cancer
por: Du, Jun, et al.
Publicado: (2012)

Platelets: Still a Therapeutical Target for Haemostatic Disorders
por: Geraldo, Reinaldo Barros, et al.
Publicado: (2014)

Platelet transfusion for cancer secondary thrombocytopenia: Platelet and cancer cell interaction
por: Wang, Juan, et al.
Publicado: (2021)

Blood Platelet Adenosine Receptors as Potential Targets for Anti-Platelet Therapy
por: Wolska, Nina, et al.
Publicado: (2019)

Zinc dysregulation in cancers and its potential as a therapeutic target
por: Wang, Jie, et al.
Publicado: (2020)

Eukaryotic ribosome quality control system: a potential therapeutic target for human diseases
por: Zhao, Peng-yue, et al.
Publicado: (2022)

New strategy for sepsis: Targeting a key role of platelet-neutrophil interaction
por: Wang, Xu, et al.
Publicado: (2014)

Potential therapeutic targets of Guggulsterone in cancer
por: Bhat, Ajaz A., et al.
Publicado: (2017)

Potential Diagnostic, Prognostic and Therapeutic Targets of MicroRNAs in Human Gastric Cancer
por: Tsai, Ming-Ming, et al.
Publicado: (2016)

SUN2: A potential therapeutic target in cancer
por: Chen, Xin, et al.
Publicado: (2019)

LncRNA SNHG16 as a potential biomarker and therapeutic target in human cancers
por: Xiao, Yuhang, et al.
Publicado: (2020)

The Complement System: A Potential Therapeutic Target in Liver Cancer
por: Yuan, Meng, et al.
Publicado: (2022)

Platelet Integrins in Tumor Metastasis: Do They Represent a Therapeutic Target?
por: Lavergne, Marion, et al.
Publicado: (2017)

Targeting Platelets for the Treatment of Cancer
por: Elaskalani, Omar, et al.
Publicado: (2017)

Subunits of human condensins are potential therapeutic targets for cancers
por: Wang, Hong-Zhen, et al.
Publicado: (2018)

The NO/cGMP/PKG pathway in platelets: The therapeutic potential of PDE5 inhibitors in platelet disorders
por: Degjoni, Anisa, et al.
Publicado: (2022)

Platelets in cardiac ischaemia/reperfusion injury: a promising therapeutic target
por: Ziegler, Melanie, et al.
Publicado: (2019)

Platelet transcriptome profiles provide potential therapeutic targets for elderly acute myelocytic leukemia patients
por: Bao, Jizhang, et al.
Publicado: (2021)

MYB oncoproteins: emerging players and potential therapeutic targets in human cancer
por: Cicirò, Ylenia, et al.
Publicado: (2021)

Therapeutic Potential of Targeting the SUMO Pathway in Cancer
por: Kukkula, Antti, et al.
Publicado: (2021)

Mechanisms and therapeutic potential of interactions between human amyloids and viruses
por: Michiels, Emiel, et al.
Publicado: (2020)

Lipocalin 2: a potential therapeutic target for breast cancer metastasis
por: Hu, Chenxia, et al.
Publicado: (2018)

RNA binding motif protein 3: a potential biomarker in cancer and therapeutic target in neuroprotection
por: Zhou, Ren-Bin, et al.
Publicado: (2017)

NALCN is a potential biomarker and therapeutic target in human cancers
por: He, Jian, et al.
Publicado: (2023)

Platelet-Derived Growth Factor as a Therapeutic Target for Systemic Autoimmune Diseases
por: Kameda, Hideto, et al.
Publicado: (2007)

Platelet–Neutrophil Interaction and Thromboinflammation in Diabetes: Considerations for Novel Therapeutic Approaches
por: Gauer, Julia S., et al.
Publicado: (2022)

MicroRNA-144: A novel biological marker and potential therapeutic target in human solid cancers
por: Zhou, Meng, et al.
Publicado: (2020)

Platelet integrin αIIbβ3: signal transduction, regulation, and its therapeutic targeting
por: Huang, Jiansong, et al.
Publicado: (2019)

Regulatory Mechanisms of Epigenetic miRNA Relationships in Human Cancer and Potential as Therapeutic Targets
por: Arif, K. M. Taufiqul, et al.
Publicado: (2020)

Sphingolipid Metabolism and Signaling in Lung Cancer: A Potential Therapeutic Target
por: Lin, Mengmeng, et al.
Publicado: (2022)

Transcription factors are potential therapeutic targets in epilepsy
por: Sun, Qihan, et al.
Publicado: (2022)

Non-Traditional Pathways for Platelet Pathophysiology in Diabetes: Implications for Future Therapeutic Targets
por: Sagar, Rebecca C., et al.
Publicado: (2022)

ER-α36: a novel biomarker and potential therapeutic target in breast cancer
por: Su, Xingyun, et al.
Publicado: (2014)

Inflammation and Joint Tissue Interactions in OA: Implications for Potential Therapeutic Approaches
por: Rainbow, Roshni, et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_laufc2tcoqk7upojl18jsij23c